Boston Scientific (BSX) Depreciation & Amortization (CF) (2020 - 2026)

Boston Scientific's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $351.0 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 8.0% year-over-year to $351.0 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 8.06% YoY), while the FY2025 annual figure was $1.4 billion, up 7.8% from the prior year.
• Depreciation & Amortization (CF) came in at $351.0 million for Q1 2026 at Boston Scientific, down from $365.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $365.0 million in Q4 2025 to a low of $274.0 million in Q1 2022.
• A 5-year average of $312.9 million and a median of $306.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) rose 1.38% in 2022 and grew 11.76% in 2025, its largest moves.
• Boston Scientific's Depreciation & Amortization (CF) stood at $294.0 million in 2022, then climbed by 6.46% to $313.0 million in 2023, then rose by 11.18% to $348.0 million in 2024, then increased by 4.89% to $365.0 million in 2025, then dropped by 3.84% to $351.0 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $351.0 million, $365.0 million, and $342.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison